EUCRATES BIOMEDICAL ACQUISITION CORP.
EUCRW 0.18
EPS (as of 2022-12-31)
Use left/right arrow keys to switch.Breakdowns
| Name | Value |
|---|
| Revenues | 0.0K |
| Cost of Revenue | 0.0K |
| Gross Profit | 0.0K |
| Operating Expense | 131.0K |
| Operating I/L | -131.0K |
| Other Income/Expense | 1,455.9K |
| Interest Income | 53.2K |
| Pretax | 1,324.9K |
| Income Tax Expense | -1,455.9K |
| Net Income/Loss | 2,780.7K |
Eucrates Biomedical Acquisition Corp.
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.
